| Dec 21 | Dec 20 | Dec 19 | Dec 18 | Dec 17 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | |||||
| Gross Profit | $ 9.77M | $ 8.27M | $ 6.01M | $ 4.64M | $ 311.33K |
| Operating Income | $ -27.98M | $ -15.25M | $ -12.69M | $ -9.16M | $ -4.07M |
| EBITDA | $ -25.88M | $ -15.21M | $ -24.96M | $ -9.20M | $ -4.07M |
| Net Income | $ -25.95M | $ -15.29M | $ -25.04M | $ -11.24M | $ -4.27M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ ― | $ ― | $ ― | $ ― | $ ― |
| Total Assets | $ 16.44M | $ 6.31M | $ 11.37M | $ 7.40M | $ 633.73K |
| Total Debt | $ 0.00 | $ 2.00M | $ 0.00 | $ 0.00 | $ 324.98K |
| Net Debt | $ -14.84M | $ -3.67M | $ -10.66M | $ -6.76M | $ 111.03K |
| Total Liabilities | $ 10.83M | $ 10.82M | $ 4.54M | $ 2.04M | $ 1.88M |
| Stockholders' Equity | $ ― | $ ― | $ ― | $ ― | $ ― |
| Cash Flow | |||||
| Free Cash Flow | $ -17.71M | $ -7.81M | $ -8.11M | $ -6.75M | $ -2.52M |
| Operating Cash Flow | $ -17.71M | $ -7.80M | $ -8.11M | $ -6.52M | $ -2.52M |
| Investing Cash Flow | |||||
| Financing Cash Flow |
Hyrecar (HYREQ)
OTHER OTC:HYREQ
